Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 2,000 shares at $43.12 ($86K) on 2014-10-09, disclosed to the SEC on 2014-10-14.
Open-market purchase of $86k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |